Ovid Therapeutics Stock (NASDAQ: OVID) stock price, news, charts, stock research, profile.
You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.
Other companies in Ovid Therapeutics’s space includes: Renovaro (NASDAQ:RENB), CytomX Therapeutics (NASDAQ:CTMX), Immuneering (NASDAQ:IMRX), Aligos Therapeutics (NASDAQ:ALGS) and Armata Pharmaceuticals (AMEX:ARMP).
Ovid Therapeutics has a consensus price target of $4.74.
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $1.06 last updated November 21, 2024 at 4:02 PM EST.
There are no upcoming dividends for Ovid Therapeutics.
Ovid Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Ovid Therapeutics.
Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.